The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The window of therapeutic opportunity in multiple sclerosis: Evidence from monoclonal antibody therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Analysis of serial measurements in medical research.
Matthews, J. N., Altman, D. G., Campbell, M. J., & Royston, P. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,136
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Self-citationReshaping human antibodies for therapy
Riechmann, L., Clark, M., Waldmann, H., & Winter, G. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,562
Self-citationAxonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Jacobs, L. D., Beck, R. W., Simon, J. H., Kinkel, R. P., Brownscheidle, C. M., Murray, T. J., Simonian, N. A., Slasor, P. J., & Sandrock, A. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431301 · Cited by 1,501
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Comi, G., Filippi, M., Barkhof, F., Durelli, L., Edan, G., Fernández, O., Hartung, H.-P., Seeldrayers, P., Sørensen, P. S., Rovaris, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04725-5 · Cited by 1,053
Confavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 996
Hartung, H.-P., Gonsette, R., Konig, N., Kwiecinski, H., Guseo, A., Morrissey, S. P., Krapf, H., & Zwingers, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)12023-x · Cited by 946
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889 · cited 1×
“Specifically, we favour the interpretation that axon degeneration results from the loss of trophic support for neurons and axons normally provided by oligodendrocytes and myelin [24, 46].”
BackgroundA longitudinal study of abnormalities on MRI and disability from multiple sclerosis
Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011341 · Cited by 861
Self-citationMeyer-Franke, A., Kaplan, M. R., Pfieger, F. W., & Barres, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90172-8 · Cited by 848
Kuhlmann, T. (2002) · Brain · doi:10.1093/brain/awf235 · Cited by 775
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.6.1419 · Cited by 602
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.1.49 · Cited by 534
Self-citationProgressive cerebral atrophy in multiple sclerosis A serial MRI study
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.6.2009 · Cited by 479
Self-citationPulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
Coles, A. J., Wing, M., Smith, S., Coraddu, F., Greer, S., Taylor, C., Weetman, A., Hale, G., Chatterjee, V. K., Waldmann, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02429-0 · Cited by 453
Self-citationStadelmann, C., Kerschensteiner, M., Misgeld, T., Brück, W., Hohlfeld, R., & Lassmann, H. (2002) · Brain · doi:10.1093/brain/awf015 · Cited by 425
Identification of a gephyrin binding motif on the glycine receptor β subunit
Meyer, G., Kirsch, J., Betz, H., & Langosch, D. (1995) · Neuron · doi:10.1016/0896-6273(95)90145-0 · Cited by 416
Wilkins, A., Majed, H., Layfield, R., Compston, A., & Chandran, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04967.2003 · Cited by 337
Induction of sodium channel clustering by oligodendrocytes
Kaplan, M. R., Meyer-Franke, A., Lambert, S., Bennett, V., Duncan, I. D., Levinson, S. R., & Barres, B. A. (1997) · Nature · doi:10.1038/386724a0 · Cited by 332
Kotter, M. R., Zhao, C., van Rooijen, N., & Franklin, R. J. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.019 · Cited by 331
Redford, E. (1997) · Brain · doi:10.1093/brain/120.12.2149 · Cited by 326
Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial
Rice, G. P. A., Filippi, M., Comi, G., & for the Cladribine Clinical Study Group and for the Cladribine MRI Study Group* (2000) · Neurology · doi:10.1212/wnl.54.5.1145 · Cited by 325
Electrically active axons degenerate when exposed to nitric oxide
Smith, K. J., Kapoor, R., Hall, S. M., & Davies, M. (2001) · Annals of Neurology · doi:10.1002/ana.96 · Cited by 320
Humanised monoclonal antibody therapy for rheumatoid arthritis
Isaacs, J. D., Hale, G., Cobbold, S. P., Waldmann, H., Watts, R. A., Hazleman, B. L., & Keogan, M. T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92294-p · Cited by 308
Self-citationBlockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration
Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., & Smith, K. J. (2003) · Annals of Neurology · doi:10.1002/ana.10443 · Cited by 252
Interferon β-1a in primary progressive MS: An exploratory, randomized, controlled trial
Leary, S. M., Miller, D. H., Stevenson, V. L., Brex, P. A., Chard, D. T., & Thompson, A. J. (2003) · Neurology · doi:10.1212/wnl.60.1.44 · Cited by 251
Self-citationSánchez, I., Hassinger, L., Paskevich, P. A., Shine, H. D., & Nixon, R. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-16-05095.1996 · Cited by 250
Molyneux, P. D., Kappos, L., Polman, C., Pozzilli, C., Barkhof, F., Filippi, M., Yousry, T., Hahn, D., Wagner, K., Ghazi, M., et al. (2000) · Brain · doi:10.1093/brain/123.11.2256 · Cited by 241
Self-citationPaolillo, A., Coles, A. J., Molyneux, P. D., Gawne–Cain, M., MacManus, D., Barker, G. J., Compston, D. A. S., & Miller, D. H. (1999) · Neurology · doi:10.1212/wnl.53.4.751 · Cited by 220
Self-citationEffect of Campath-1H antibody on human hematopoietic progenitors in vitro
Gilleece, M., & Dexter, T. (1993) · Blood · doi:10.1182/blood.v82.3.807.807 · Cited by 217
Autoimmune disease in first-degree relatives of patients with multiple sclerosis
Broadley, S. A., Deans, J., Sawcer, S. J., Clayton, D., & Compston, D. A. S. (2000) · Brain · doi:10.1093/brain/123.6.1102 · Cited by 210
Self-citationFormation of Compact Myelin Is Required for Maturation of the Axonal Cytoskeleton
Brady, S. T., Witt, A. S., Kirkpatrick, L. L., de Waegh, S. M., Readhead, C., Tu, P.-H., & Lee, V. M.-Y. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07278.1999 · Cited by 197
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
Bechtold, D. A., Kapoor, R., & Smith, K. J. (2004) · Annals of Neurology · doi:10.1002/ana.20045 · Cited by 192
Moreau, T., Scolding, N., Compston, A., Thorpe, J., Miller, D., Moseley, I., Hale, G., Waldmann, H., Clayton, D., Wing, M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91339-0 · Cited by 187
Self-citationA role for oligodendrocyte‐derived IGF‐1 in trophic support of cortical neurons
Wilkins, A., Chandran, S., & Compston, A. (2001) · Glia · doi:10.1002/glia.1094 · Cited by 185
Miller, D. H., Molyneux, P. D., Barker, G. J., MacManus, D. G., MOSELEY, I. F., Wagner, K., & the European Study Group on Interferon-?1b in Secondary Progressive Multiple Sclerosis (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6<850::aid-ana7>3.0.co;2-q · Cited by 158
Self-citationTreatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies
Lockwood, C. M., Thiru, S. S., Stewart, S., Hale, G., Isaacs, J. D., WRAIGHT, P. R., Elliott, J., & Waldmann, H. (1996) · QJM · doi:10.1093/qjmed/89.12.903 · Cited by 129
Self-citationWhole brain volume changes in patients with progressive MS treated with cladribine
Filippi, M., Rovaris, M., Iannucci, G., Mennea, S., Sormani, M. P., & Comı, G. (2000) · Neurology · doi:10.1212/wnl.55.11.1714 · Cited by 127
The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway
Colello, R. J., Pott, U., & Schwab, M. E. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02594.1994 · Cited by 115
Chard, D., Brex, P. A., Ciccarelli, O., Griffin, C. M., Parker, G. J. M., Dalton, C., Altmann, D. R., Thompson, A. J., & Miller, D. H. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.11.1551 · Cited by 110
Self-citationCAMPATH-1H IN RHEUMATOID ARTHRITIS—AN INTRAVENOUS DOSE-RANGING STUDY
Isaacs, J. D., Manna, V. K., Rapson, N. T., Bulpitt, K. J., Hazleman, B. L., Matteson, E. L., Clair, E. W. S., Schnitzer, T. J., & JOHNSTON, J. M. (1996) · Rheumatology · doi:10.1093/rheumatology/35.3.231 · Cited by 110
Golde, S., Chandran, S., Brown, G. C., & Compston, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00973.x · Cited by 84
Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
Hale, G., & Waldmann, H. (1996) · PubMed · Cited by 70
Self-citationRotondi, M., Oliviero, A., Profice, P., Mone, C. M., Biondi, B., Buono, A. D., Mazziotti, G., Sinisi, A. M., Bellastella, A., & Carella, C. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03348040 · Cited by 66
Liver and thyroid function and autoimmunity during interferon-β1b treatment for MS
Durelli, L., Ferrero, B., Oggero, A., Verdun, E., Ghezzi, A., Montanari, E., Zaffaroni, M., & the Betaferon Safety Trial (BEST) Study Group (2001) · Neurology · doi:10.1212/wnl.57.8.1363 · Cited by 55
Monzani, F., Caraccio, N., Meucci, G., Lombardo, F. P., Moscato, G., Casolaro, A., Ferdeghini, M., Murri, L., & Ferrannini, E. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410325 · Cited by 42
Durelli, L., Oggero, A., Verdun, E., Isoardo, G., Barbero, P., Bergamasco, B., Brossa, P. C., Ghigo, E., Maccario, M., & Faggiano, F. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00637-2 · Cited by 36
Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
Isaacs, J. D., Hazleman, B. L., Chakravarty, K., et al. (1996) · PubMed · Cited by 34
Annunziata, P., Loré, F., Venturini, E., Morana, P., Guarino, E., Borghi, S., & Guazzi, G. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00168-9 · Cited by 34
Verdun, E., Isoardo, G., Oggero, A., Ferrero, B., Ghezzi, A., Montanari, E., Zaffaroni, M., & Durelli, L. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753536220 · Cited by 33
Nicholas, R. S., Compston, A., & Brown, D. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00141.x · Cited by 27
Transcallosal bands: A sign of neuronal tract degeneration in early MS?
Simon, J. H., Jacobs, L. R., & Kinkel, R. P. (2001) · Neurology · doi:10.1212/wnl.57.10.1888 · Cited by 23
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Self-citationDobson, R., & Giovannoni, G. (2019) · European Journal of Neurology · doi:10.1111/ene.13819 · Cited by 2,148
Cohen, J. A., Coles, A. J., Arnold, D. L., Confavreux, C., Fox, E. J., Hartung, H.-P., Havrdova, E., Selmaj, K. W., Weiner, H. L., Fisher, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61769-3 · Cited by 1,205
Self-citationColes, A. J., Twyman, C. L., Arnold, D. L., Cohen, J. A., Confavreux, C., Fox, E. J., Hartung, H.-P., Havrdova, E., Selmaj, K. W., Weiner, H. L., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61768-1 · Cited by 1,198
Self-citationThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Metadata
- Authors
- Coles, A. J., Cox, A., Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., & Compston, D. A.
- Venue
- Journal of Neurology
- Published
- 2005-07-27
- Volume
- 253
- Issue
- 1
- Pages
- 98-108
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W1975254445
- Cited by
- 506
- References
- 58
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.